Look for:

Our offer for

KONINKLIJKE PHILIPS NV


ISIN:
NL0000009538
WKN:
0953

2023/06/02 17:35:46
Price
18.156 EUR
Difference 2.22% (0.39)

General attributes

ISINNL0000009538
SymbolPHIA
ExchangeEuronext Amsterdam
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,718 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)18.00 EUR (174)
Ask (Ask size)18.28 EUR (500)
Open17.788 EUR
High18.23 EUR
Low17.752 EUR
Close (prev. day)17.762 EUR
VWAP18.112402 EUR
Volume (pcs)1,846,252
Trading volume33,440,059.00
Number of trades5,081
Last size4,232

Futures and Options

Related Futures53
Related Options-

PDF Downloads

Company report: KONINKLIJKE PHILIPS NVPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/06/02 17:35:46
Price
18.156 EUR
Difference 2.22% (0.39)

General attributes

ISINNL0000009538
SymbolPHIA
ExchangeEuronext Amsterdam
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,718 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)18.00 EUR (174)
Ask (Ask size)18.28 EUR (500)
Open17.788 EUR
High18.23 EUR
Low17.752 EUR
Close (prev. day)17.762 EUR
VWAP18.112402 EUR
Volume (pcs)1,846,252
Trading volume33,440,059.00
Number of trades5,081
Last size4,232

Performance and Risk

6m1Y3Y
Perf (%)+30.81%-17.84%-52.69%
Perf (abs.)+4.28-3.94-20.22
Beta1.221.210.99
Volatility39.7442.0934.72
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)18.015 EUR (3,128,941)
Ø price 30 days | Ø volume 30 days (pcs.)18.371 EUR (2,913,170)
Ø price 100 days | Ø volume 100 days (pcs.)16.158 EUR (3,408,153)
Ø price 250 days | Ø volume 250 days (pcs.)16.019 EUR (3,884,832)
YTD High | date20.255 EUR (2023/05/16)
YTD Low | date13.484 EUR (2023/01/02)
52 Weeks High | date22.869 EUR (2022/06/08)
52 Weeks Low | date11.611 EUR (2022/11/03)

All listings for KONINKLIJKE PHILIPS NV

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/06/0217:3518.148 EUR0.0416
Vienna Stock Exchange2023/06/0209:0517.852 EUR0.003
Tradegate2023/06/0222:2618.158 EUR0.2350
Stuttgart2023/06/0216:3618.128 EUR0.0117
SIX Swiss Exchange2022/06/0215:2047.0683 CHF0.001
Munich2023/06/0208:0017.842 EUR0.001
London Stock Exchange European Trade Reporting2023/06/0217:3018.149 EUR0.001
Hanover2023/06/0208:0017.838 EUR0.001
Hamburg2023/06/0214:5018.08 EUR0.012
Frankfurt2023/06/0217:3518.136 EUR0.1113
FINRA other OTC Issues2023/06/0119:2718.89 USD0.003
Euronext Milan MTF Trading After Hours2023/02/1320:1215.704 EUR0.001
Euronext Milan MTF Global Equity Market2023/06/0217:4418.128 EUR0.002
Euronext Amsterdam2023/06/0217:3518.156 EUR33.445,081
Duesseldorf2023/06/0221:0018.086 EUR0.0010
Berlin2023/06/0221:5218.166 EUR0.0016
BX Swiss2023/06/0218:0017.596 CHF0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2324&ID_TYPE_IMAGE_LOGO=2

Contact Details

KONINKLIJKE PHILIPS NV
- -
Philips Center, Amstelplein 2 - 1096 BC Amsterdam
Telefon: +31-20-597-77-77
Fax: +
E-mail: -

PDF Downloads

Company report: KONINKLIJKE PHILIPS NVPDF Download

Company Profile

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Members of Management Board

Frans von HoutenChairman of Managing Board
Abhijit BhattacharyaMember of Executive Committee
Andy HoMember of Executive Committee
Bert van MeursMember of Executive Committee
Daniela SeabrookMember of Executive Committee
Deeptha KhannaMember of Executive Committee
Edwin PaalvastMember of Executive Committee
Kees WesdorpMember of Executive Committee
Marnix van GinnekenMember of Executive Committee
Roy JakobsMember of Executive Committee
Shez PartoviMember of Executive Committee
Sophie BechuMember of Executive Committee
Vitor RochaMember of Executive Committee

Board of directors

Feike SijbesmaChairman of Supervisory Board
A. HarrisonMember of Supervisory Board
Paulus StoffelsMember of Supervisory Board
David PyottMember of Supervisory Board
Herna VerhagenMember of Supervisory Board
Indra Krishnamurthy NooyiMember of Supervisory Board
Mary DohertyMember of Supervisory Board
Peter D. LöscherMember of Supervisory Board
Sanjay PoonenMember of Supervisory Board
Sock Koong ChuaMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer